Dendritic cell prostate cancer vaccine is enhanced by inhibiting the SH2-domaincontaining phosphatase, SHP-1

被引：0
|
作者：
Levitt, J. M.
Ramachandran, I.
机构：
[1] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[2] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA
来源：
BJU INTERNATIONAL | 2007年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] RING finger protein 38 induces gastric cancer cell growth by decreasing the stability of the protein tyrosine phosphatase SHP-1
    Zhang, Jigang
    Wu, Hao
    Yi, Bin
    Zhou, Jian
    Wei, Luxin
    Chen, Yan
    Zhang, Lifeng
    FEBS LETTERS, 2018, 592 (18): : 3092 - 3100
  • [32] A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
    Burshtyn, DN
    Yang, WT
    Yi, TL
    Long, EO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) : 13066 - 13072
  • [33] CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: Involvement of SH2-containing phosphotyrosine phosphatase SHP-1
    Perez-Villar, JJ
    Whitney, GS
    Bowen, MA
    Hewgill, DH
    Aruffo, AA
    Kanner, SB
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (04) : 2903 - 2912
  • [34] SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production
    Meng, Fei
    Zhao, Xiaoyun
    Zhang, Shulan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (01) : 272 - 279
  • [35] Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase
    Ram, PA
    Waxman, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) : 17694 - 17702
  • [36] Insufficient phosphorylation prevents FcγRIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1
    Lesourne, R
    Bruhns, P
    Fridman, WH
    Daëron, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) : 6327 - 6336
  • [37] Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1
    Imhof, D
    Wieligmann, K
    Hampel, K
    Nothmann, D
    Zoda, MS
    Schmidt-Arras, D
    Zacharias, M
    Böhmer, FD
    Reissmann, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) : 1528 - 1539
  • [38] Aberrant methylation of SHP-1 (SH2-containing phosphatase 1) and SOCs-1 (suppressor of cytokine signalling 1) genes in immunodeficiency-related lymphomas
    Cerri, M.
    Deambrogi, C.
    Rossi, D.
    Lunghi, M.
    Zigrossi, P.
    Spina, V.
    De Paoli, L.
    Riccomagno, P.
    Gloghini, A.
    Lucioni, M.
    Capello, D.
    Paulli, M.
    Carbone, A.
    Gaidano, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 105 - 105
  • [39] Role of HTLV-1 Tax in Sh2-containing tyrosine phosphatase-1 (Shp-1) promoter silencing in acute infection and adult T-cell leukemia (ATL)
    Marasco, WAM
    Cheng, J
    Noonan, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) : 499 - 499
  • [40] A variant SHP-1 protein tyrosine phosphatase having only an aminoterminal SH2 domain may act as a tumor promoter for lymphomagenesis.
    Branch, DR
    Sakac, D
    Fahim, S
    Wan, S
    Ma, XZ
    BLOOD, 2002, 100 (11) : 204B - 205B
12345